Effect of cassia auriculata l on erythrocyte membrane bound enzymes and antioxidant status in experimental diabetes
Cassia auriculata L. (Ceasalpiniaceae) has been used traditionally as antidiabetic and has been proven scientifically to possess high antioxidant activity and anticancer properties. In the present study the effect of Cassia auriculata L (CFEt) and glibenclamide on erythrocyte membrane bound enzymes and antioxidants activity in streptozotocin (STZ) and nicotinamide induced type 2 diabetic model was investigated. Oral administration of CFEt at 0.45 mg/kg body weight to diabetic rats for 45 days.